BENZAMYCIN Drug Patent Profile
✉ Email this page to a colleague
When do Benzamycin patents expire, and when can generic versions of Benzamycin launch?
Benzamycin is a drug marketed by Valeant Intl and is included in one NDA.
The generic ingredient in BENZAMYCIN is benzoyl peroxide; erythromycin. There are seventeen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the benzoyl peroxide; erythromycin profile page.
Summary for BENZAMYCIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 103 |
Patent Applications: | 6,230 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for BENZAMYCIN |
What excipients (inactive ingredients) are in BENZAMYCIN? | BENZAMYCIN excipients list |
DailyMed Link: | BENZAMYCIN at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for BENZAMYCIN
US Patents and Regulatory Information for BENZAMYCIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Valeant Intl | BENZAMYCIN | benzoyl peroxide; erythromycin | GEL;TOPICAL | 050557-001 | Oct 26, 1984 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |